Bluestar genomics + press release
WebJan 10, 2024 · Bluestar Genomics is an early cancer detection company focused on the development and commercialization of non-invasive epigenomic tests to detect cancer through a standard blood draw, earlier... WebOct 10, 2024 · Press Release Bluestar Genomics Receives CAP Accreditation for Its Clinical Laboratory Published: Oct. 10, 2024 at 8:00 a.m. ET CAP-accredited, CLIA …
Bluestar genomics + press release
Did you know?
WebFounded Date Jan 1, 2016. Founders Samuel Levy. Operating Status Closed. Last Funding Type Series C. Legal Name Bluestar Genomics, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number (833) 258-7827. Bluestar Genomics delivers epigenomic and big data approaches to reinvent non-invasive molecular … WebJun 15, 2024 · The case is 3:21-cv-04507, Bluestar Genomics v. Song et al. This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates …
WebMay 12, 2024 · SAN DIEGO-- ( BUSINESS WIRE )-- Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early … WebClearNote Health to present at 41st annual J.P. Morgan Healthcare Conference (ClearNote Health Press Release) "ClearNote Health™ (formerly known as Bluestar Genomics)...announced that Chief Executive Officer Dave Mullarkey will present a company update at the 41st annual J.P. Morgan Healthcare Conference on Wednesday, January …
Web27 minutes ago · Contact Data CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For ... WebDec 21, 2024 · Bluestar Genomics today announced the company’s U.S. and international commercialization of its first test for early detection of pancreatic cancer in high-risk patients, and unveiled a new name, ClearNote Health™. ... This press release features multimedia. View the full release here: ...
WebPress Releases March 8, 2016 – Courtagen and Medicinal Genomics Announce Expanded Speaker List for CannMed 2016 – 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April The conference will feature internationally recognized thought leaders, scientists, physicians, and advocates working to advance research into …
WebSep 12, 2024 · Press release content from Business Wire. The AP news staff was not involved in its creation. Bluestar Genomics Presents Data on New Applications of its … thomas hustermann dortmundWebSep 12, 2024 · Bluestar Genomics is an early cancer detection company focused on the development and commercialization of non-invasive epigenomic tests to detect cancer through a standard blood draw, earlier than existing methods and when the disease is … ugly soccer bootsWebMay 12, 2024 · Series C investments and scientific advisory board membership expansion are largely inspired by Bluestar Genomics' groundbreaking technology platform that … thomas husted md cincinnatiWebDec 21, 2024 · December 21, 2024 SAN DIEGO-- (BUSINESS WIRE)--Dec 21, 2024-- Bluestar Genomics today announced the company’s U.S. and international … ugly soccer jerseysWebClearNote Health (formerly Bluestar Genomics) 1 year 9 months Vice President Communications ClearNote Health (formerly Bluestar … thomas huster castropWebOct 10, 2024 · Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests focused on non-invasive detection of high-mortality cancers in high-risk patient populations, today announced it received accreditation for its clinical laboratory from the College of … ugly soccer cleatsWebMar 31, 2024 · Bluestar Genomics, an epigenomics-based molecular cancer testing company, develops next-generation epigenomic approaches to detect deadly cancers, … thomas huster attorney